BLRX

News BioLineRx (BLRX) Q1 2026 Earnings Transcript

3d ago

News BioLineRx GAAP EPS of $0.00 beats by $1.04, revenue of $0.48M beats by $0.14M

6d ago

SEC filing BLRX Doses 1st Patient in GLIX1 GBM Trial, $0.5M Royalties, $17.4M Cash

6d ago

SEC filing BLRX and Hemispherian Report GLIX1 Preclinical Data Showing Potent Anti-Tumor Effect in Glioblastoma Models

14d ago

SEC filing BLRX Initiates Phase 1/2a GLIX1 Study for GBM, Oral TET2 Activator, 30-Patient MTD Trial, NYU Langone Leads, Data H1 2027

68d ago

SEC filing BLRX Reports $20.9M Cash, $0.00 EPS, Announces Phase 1/2a GLIX1 GBM Trial Start, Patent Allowed Until 2040, Motixafortide Pancreatic Trial Accelerated

71d ago

Scanner Unusual volume (10.7x average)

125d ago

News Evocative Raises Financing to Fuel Continued Growth

168d ago

News Medical Supplier Medline Guides IPO to Upper Half of Price Range

168d ago

News Kenya Awards AfDB and Power Grid India $311 Million Deal for Lines

169d ago

News Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

169d ago